Federal Court Echoes PTAB Ruling Invalidating Zytiga Patent By Sam | October 30, 2018 A New Jersey federal court threw out Johnson & Johnson’s patent on a top-selling prostate cancer treatment. Source: Drug Industry Daily Posted in Drug Industry Daily